1 / 6

Pet Cancer Therapeutics Market forecast to see more than 10% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2vzOqU5 <br>The Pet cancer therapeutics sector is a relatively new compared to other pet healthcare sectors. Increasing trend of pet adoption such as dogs and cats owing to improved economic status of people will drive pet cancer therapeutics market size.

jueekate
Download Presentation

Pet Cancer Therapeutics Market forecast to see more than 10% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pet Cancer Therapeutics Market forecast to reach $300mn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Pet Cancer Therapeutics Market: • Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years. • High cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion. • Chemotherapy has been the mainstream medication for pet cancers till recent times. • Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth. • Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types.

  3. Continued... • This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth. • U.S. pet cancer therapeutics market holds the largest revenue share in 2016. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth. • Australia pet cancer therapeutics market held highest regional revenue share in 2016 owing to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners. • Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, KaryopharmsVerdinexor. • The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition.

  4. U.S Pet cancer therapeutics market, by medicine type, 2013 - 2024 (USD Million)

  5. Browse Full Market Research Report On Pet Cancer Therapeutics Market @ http://bit.ly/2fxZquX Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/2017https://www.gminsights.com/request-sample/detail/49

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related